Moderna, a clinical-stage biopharmaceutical company developing messenger RNA (mRNA) therapeutics and vaccines, has reported positive interim efficacy data of its COVID-19 vaccine candidate, mRNA-1273, from a Phase III study, which…
Pharma COVID Roundup: News from Lilly, GSK, AstraZeneca, Novartis
The latest on manufacturing and potential treatments for COVID-19 with news from CSL, Regeneron, Lilly, AstraZeneca, Novartis, GSK, Novavax, CSL, Moderna, and others. Manufacturing and supply of COVID-19 vaccines and…
Global Pharma Briefs: News from Biogen, Biocon, and bluebird bio
A roundup of news from India (Biocon) and the US (Biogen and bluebird bio). India Biocon Biologics OKs $150-M Capital Injection from Goldman SachsThe board of Biocon Biologics, a biosimilars…
Pfizer, BioNTech Report 90% Effectiveness for COVID-19 Vaccine
Pfizer and BioNTech, a Mainz, Germany-based immunotherapy company, have reported positive interim efficacy data of their COVID-19 vaccine candidate, BNT162b2, from a Phase III study, which found the vaccine to…
Pharma COVID Roundup: News from J&J, Novavax, Regeneron, CureVac
The latest on manufacturing and potential treatments for COVID-19 with news from Johnson & Johnson, Novavax, Regeneron, CureVac, Aspen Pharmacare, and others. Manufacturing and supply of COVID-19 vaccines and drugs…
J&J, AstraZeneca To Resume Clinical Trials in the US for COVID-19 Vaccines
Johnson & Johnson (J&J) and AstraZeneca have announced plans to resume clinical trials in the US for their respective COVID-19 vaccine candidates after earlier pausing trials due to an unexpected…
FDA OKs Gilead’s Remdesivir as First Drug in US to Treat COVID-19
The US Food and Drug Administration (FDA) has approved Gilead Sciences’ antiviral drug, Veklury (remdesivir), for treating hospitalized COVID-19 patients, making it the first drug in the US to receive…
Pharma COVID Roundup: News from Sanofi, GSK, Novartis, Takeda, BI
The latest on manufacturing and potential treatments for COVID-19 with news from Sanofi, GSK, Novartis, Takeda, BI, Moderna, Regeneron, and Novavax. Manufacturing and supply news for COVID-19 vaccines and drugs…
Lilly, US Gov’t Form $375-M Supply Pact for COVID-19 mAb Candidate
Eli Lilly and Company has entered into an agreement for $375 million with the US government to supply 300,000 vials of LY-CoV555 (bamlanivimab) (700 mg), the company’s investigational monoclonal antibody…
Pharma COVID Roundup: News from AstraZeneca, Moderna, J&J, BMS, AbbVie
The latest on manufacturing and potential treatments for COVID-19 with news from AstraZeneca, Moderna, Roche, J&J, BMS, AbbVie, Sanofi, Fujifilm, and others. Manufacturing and supply news for COVID-19 vaccines and…
